Movetis
From Wikipedia, the free encyclopedia
Company typePublic company
Founded2006
FoundersStaf Van Reet, Remi Van den Broeck, Dirk Reyn, Jan Schuurkes, and Johnson & Johnson
Defunct2010
| Company type | Public company |
|---|---|
| Founded | 2006 |
| Founders | Staf Van Reet, Remi Van den Broeck, Dirk Reyn, Jan Schuurkes, and Johnson & Johnson |
| Defunct | 2010 |
| Fate | Acquired |
| Successor | Shire (pharmaceutical company) |
| Headquarters | |
Area served | Worldwide |
Key people | Staf Van Reet (CEO) |
| Products | Gastro-intestinal drugs |
| Website | www.movetis.com at the Wayback Machine (archived January 7, 2010) |
Movetis was a pharmaceutical company headquartered in Belgium. It was founded in 2006 as a spin-off from parent company Johnson & Johnson. The company specialized in pharmaceuticals for treating gastro-intestinal disorders. It was acquired by Shire in 2010.
The primary drug produced by Movetis was Prucalopride (known by the brand name "Resolor"), indicated for cases of chronic constipation.